XBIOTECH INC.
Income Statement
| Line Item | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $300.0K | $1.7M | $1.5M | $500.0K |
| Cost of Revenue | $0 | $0 | $0 | $0 | $16.0K | $215.0K | $207.0K | $213.0K |
| Gross Profit | $0 | $0 | $0 | $0 | $284.0K | $1.5M | $1.3M | $287.0K |
| Gross Margin | — | — | — | — | 94.7% | 87.2% | 86.5% | 57.4% |
| Operating Expenses | ||||||||
| Research & Development | $7.8M | $7.5M | $11.3M | $6.2M | $7.3M | $7.0M | $10.4M | $6.8M |
| SG&A Expense | $782.0K | $973.0K | $2.0M | $915.0K | $1.1M | $840.0K | $3.0M | $1.3M |
| Operating Income | $-8.6M | $-8.5M | $-13.3M | $-7.1M | $-8.2M | $-6.4M | $-12.1M | $-7.8M |
| Operating Margin | — | — | — | — | -2,720.7% | -380.3% | -790.5% | -1,569.0% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-4.7M | $-7.1M | $-8.7M | $-3.9M | $-2.6M | $-10.3M | $-14.3M | $-6.5M |
| Income Tax Expense | $-172.0K | $308.0K | $71.0K | $37.0K | $578.0K | $2.4M | $-2.6M | $-1.1M |
| Net Income | $-4.6M | $-7.4M | $-8.7M | $-3.8M | $-3.2M | $-12.7M | $-11.6M | $-5.4M |
| Net Margin | — | — | — | — | -1,067.7% | -753.5% | -761.0% | -1,079.0% |
| EPS (Basic) | $-0.15 | $-0.24 | $-0.29 | $-0.13 | $-0.10 | $-0.42 | $-0.38 | $-0.18 |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | 30.4M | 30.4M | 30.4M | 30.4M | 30.4M | 30.4M | 30.4M | 30.4M |
| Shares Outstanding (Diluted) | 30.4M | 30.4M | 30.4M | 30.4M | 30.4M | 30.4M | 30.4M | 30.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |